Alcohol-Related Liver Disease: Is There a Safe Alcohol Consumption Limit for Liver Disease?

Abstract

This review is to evaluate how much alcohol is safe in the context of alcohol-related liver disease (ALD). In patients without an established diagnosis of ALD consuming alcohol at quantities below 12 to 20 g daily with alcohol-free days is associated with a very low risk of developing disease. This risk is mediated by the presence of cofactors such as sex, medical comorbidity, obesity, and genetic factors. A threshold effect below which liver disease will not occur is not seen, instead a dose–response relationship where risk ranges from low to high. Once ALD is present, natural history studies confirm that continued alcohol consumption is clearly associated with an increased risk of ill health and premature death. In conclusion, low-level alcohol consumption in the absence of liver disease is associated with a very small risk of developing ALD, but once ALD is present patients should be supported to achieve complete abstinence from alcohol.

Keywords

alcohol - lifestyles - behavior - risk reduction - alcoholic cirrhosis

Publikationsverlauf

Artikel online veröffentlicht:
28. August 2023

• References

• 1 Rehm J, Shield KD. Global burden of alcohol use disorders and alcohol liver disease. Biomedicines 2019; 7 (04) 99
• 2 Amonker S, Houshmand A, Hinkson A, Rowe I, Parker R. Prevalence of alcohol-associated liver disease: a systematic review and meta-analysis. Hepatol Commun 2023; 7 (05) e0133
• 3 Müller PC, Kabacam G, Vibert E, Germani G, Petrowsky H. Current status of liver transplantation in Europe. Int J Surg 2020; 82S (October): 22-29
• 4 Younossi ZM, Stepanova M, Ong J. et al. Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States. Clin Gastroenterol Hepatol 2021; 19 (03) 580-589.e5
• 5 Singal AK, Arora S, Wong RJ. et al. Increasing burden of acute-on-chronic liver failure among alcohol-associated liver disease in the young population in the United States. Am J Gastroenterol 2020; 115 (01) 88-95
• 6 Dhanda A, Bodger K, Hood S. et al; BASL ARLD SIG National Service Evaluation Group. The Liverpool alcohol-related liver disease algorithm identifies twice as many emergency admissions compared to standard methods when applied to Hospital Episode Statistics for England. Aliment Pharmacol Ther 2023; 57 (04) 368-377
• 7 Julien J, Ayer T, Tapper EB, Barbosa C, Dowd WN, Chhatwal J. Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-associated liver disease: a modeling study. Hepatology 2022; 75 (06) 1480-1490
• 8 Bellentani S, Saccoccio G, Costa G. et al; The Dionysos Study Group. Drinking habits as cofactors of risk for alcohol induced liver damage. Gut 1997; 41 (06) 845-850
• 9 Esser MB, Sherk A, Subbaraman MS. et al. Improving estimates of alcohol-attributable deaths in the United States: impact of adjusting for the underreporting of alcohol consumption. J Stud Alcohol Drugs 2022; 83 (01) 134-144
• 10 Rehm J, Taylor B, Mohapatra S. et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev 2010; 29 (04) 437-445
• 11 Roerecke M, Vafaei A, Hasan OSM. et al. Alcohol consumption and risk of liver cirrhosis: a systematic review and meta-analysis. Am J Gastroenterol 2019; 114 (10) 1574-1586
• 12 Askgaard G, Grønbæk M, Kjær MS, Tjønneland A, Tolstrup JS. Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study. J Hepatol 2015; 62 (05) 1061-1067
• 13 Llamosas-Falcón L, Probst C, Buckley C. et al. Sex-specific association between alcohol consumption and liver cirrhosis: an updated systematic review and meta-analysis. Front Gastroenterol (Lausanne) 2022; 1 (October): 1005729
• 14 Mitchell T, Jeffrey GP, de Boer B. et al. Type and pattern of alcohol consumption is associated with liver fibrosis in patients with non-alcoholic fatty liver disease. Am J Gastroenterol 2018; 113 (10) 1484-1493
• 15 Pose E, Pera G, Torán P. et al. Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: a population-based study. Liver Int 2021; 41 (07) 1556-1564
• 16 Åberg F, Helenius-Hietala J, Puukka P, Jula A. Binge drinking and the risk of liver events: a population-based cohort study. Liver Int 2017; 37 (09) 1373-1381
• 17 Åberg F, Puukka P, Salomaa V. et al. Combined effects of alcohol and metabolic disorders in patients with chronic liver disease. Clin Gastroenterol Hepatol 2020; 18 (04) 995-997.e2
• 18 Pearson MM, Kim NJ, Berry K. et al. Associations between alcohol use and liver-related outcomes in a large national cohort of patients with cirrhosis. Hepatol Commun 2021; 5 (12) 2080-2095
• 19 Sanchez-Roige S, Palmer AA, Fontanillas P. et al; 23andMe Research Team, the Substance Use Disorder Working Group of the Psychiatric Genomics Consortium. Genome-wide association study meta-analysis of the Alcohol Use Disorders Identification Test (AUDIT) in two population-based cohorts. Am J Psychiatry 2019; 176 (02) 107-118
• 20 Tolstrup JS, Grønbaek M, Tybjaerg-Hansen A, Nordestgaard BG. Alcohol intake, alcohol dehydrogenase genotypes, and liver damage and disease in the Danish general population. Am J Gastroenterol 2009; 104 (09) 2182-2188
• 21 Whitfield JB. Meta-analysis of the effects of alcohol dehydrogenase genotype on alcohol dependence and alcoholic liver disease. Alcohol Alcohol 1997; 32 (05) 613-619
• 22 Borràs E, Coutelle C, Rosell A. et al. Genetic polymorphism of alcohol dehydrogenase in Europeans: the ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1. Hepatology 2000; 31 (04) 984-989
• 23 Vidal F, Lorenzo A, Auguet T. et al. Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in Spanish men: lack of association with alcoholism and alcoholic liver disease. J Hepatol 2004; 41 (05) 744-750
• 24 Stickel F, Buch S, Lau K. et al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in Caucasians. Hepatology 2011; 53 (01) 86-95
• 25 Stickel F, Lutz P, Buch S. et al. Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers. Hepatology 2020; 72 (01) 88-102
• 26 Johansen S, Thiele M, Juel HB, Hansen T, Krag A. External validation of a genetic risk score that predicts development of alcohol-related cirrhosis. J Hepatol 2022; 77 (06) 1720-1721
• 27 Whitfield JB, Schwantes-An T-H, Darlay R. et al; GenomALC Consortium. A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers. J Hepatol 2022; 76 (02) 275-282
• 28 Hakim A, Moll M, Qiao D. et al. Heterozygosity of the alpha 1-antitrypsin Pi*Z allele and risk of liver disease. Hepatol Commun 2021; 5 (08) 1348-1361
• 29 Parker R, Aithal GP, Becker U. et al; WALDO Study Group. Natural history of histologically proven alcohol-related liver disease: a systematic review. J Hepatol 2019; 71 (03) 586-593
• 30 Lackner C, Spindelboeck W, Haybaeck J. et al. Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease. J Hepatol 2017; 66 (03) 610-618
• 31 Hagström H, Thiele M, Roelstraete B, Söderling J, Ludvigsson JF. Mortality in biopsy-proven alcohol-related liver disease: a population-based nationwide cohort study of 3453 patients. Gut 2021; 70 (01) 170-179
• 32 Louvet A, Bourcier V, Archambeaud I. et al; CIRRAL Group. Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort. J Hepatol 2023; 78 (03) 501-512
• 33 Lucey MR, Connor JT, Boyer TD, Henderson JM, Rikkers LF. DIVERT Study Group. Alcohol consumption by cirrhotic subjects: patterns of use and effects on liver function. Am J Gastroenterol 2008; 103 (07) 1698-1706
• 34 Atkinson SR, Way MJ, McQuillin A, Morgan MY, Thursz MR. Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis. J Hepatol 2017; 67 (01) 120-127
• 35 Altamirano J, López-Pelayo H, Michelena J. et al. Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long-term survival. Hepatology 2017; 66 (06) 1842-1853
• 36 Theodoreson MD, Aithal GP, Allison M. et al. Extra-hepatic morbidity and mortality in alcohol-related liver disease: systematic review and meta-analysis. Liver Int 2023; 43 (04) 763-772
• 37 Madsen BS, Thiele M, Detlefsen S. et al; GALAXY Consortium. PRO-C3 and ADAPT algorithm accurately identify patients with advanced fibrosis due to alcohol-related liver disease. Aliment Pharmacol Ther 2021; 54 (05) 699-708